Statistical analysis using two- and one-sided Fisher exact tests of ultra-rare plus novel and rare germline heterozygous variants in RPA1, RPA2 and RPA3 across hematologic, extra-cranial solid and CNS tumors. Here, RPA2 is linked to central nervous system neoplasm.